General commentary to the Management of biochemical recurrence after primary localized therapy for prostate cancer by Darwish O. M. and Raj G. V. by Mark eShilkrut, Felix eFeng, Daniel A Hamstra

Get full text

Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now? by Arpit Rao, Nagaishwarya Moka, Daniel A. Hamstra, Charles J. Ryan

Get full text

A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life by Zachary A. Seymour, Zachary A. Seymour, Michael Pinkawa, Michael Pinkawa, Stephanie Daignault-Newton, Walter Bosch, Jeff M. Michalski, Hiram Gay, Daniel A. Hamstra, Daniel A. Hamstra

Get full text

Predictors of follow-up non-compliance after definitive radiotherapy for locally advanced cervical cancer at a community cancer center by Lucas G. Sapienza, Justin J. Thomas, Alfredo E. Echeverria, Shelly Sharma, Daniel A. Hamstra, Tracilyn R. Hall, Michelle S. Ludwig

Get full text

Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer by Elizabeth E. Dong, Junqian Xu, Joo-Won Kim, Jason Bryan, Jewel Appleton, Daniel A. Hamstra, Michelle S. Ludwig, Alexander N. Hanania

Get full text

Imaging of Proteolytic Activity Using a Conditional Cell Surface Receptor by Mahaveer Swaroop Bhojani, Daniel A. Hamstra, Daniel C. Chang, Julia M. Coppola, Amjad P. Khan, G. Ramachandra Reddy, Brian D. Ross, Alnawaz Rehemtulla

Get full text

MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner by Felix Y. Feng, Yu Zhang, Vishal Kothari, Joseph R. Evans, William C. Jackson, Wei Chen, Skyler B. Johnson, Connor Luczak, Shaomeng Wang, Daniel A. Hamstra

Get full text

Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment by Zachary A. Seymour, Stephanie Daignault-Newton, P.W. McLaughlin, Howard Sandler, William Jackson, Skyler B. Johnson, David Miller, John Wei, Martin Sanda, Daniel A. Hamstra

Get full text

Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series by Zachary B. Koloff, Daniel A. Hamstra, John T. Wei, Jeffrey S. Montgomery, Scott A. Tomlins, Angela J. Wu, Todd M. Morgan, Javed Siddiqui, Kellie Paich, Arul M. Chinnaiyan, Felix Y. Feng, Alon Z. Weizer, Lakshmi P. Kunju, Brent K. Hollenbeck, David C. Miller, Ganesh S. Palapattu, Rohit Mehra

Get full text

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy by William C. Jackson, MD, Felix Y. Feng, MD, Stephanie Daignault, PhD, Maha Hussain, MD, David Smith, MD, Kathleen Cooney, MD, Kenneth Pienta, MD, Shruti Jolly, MD, Brent Hollenbeck, MD, Karin B. Olson, PA-C, Howard M. Sandler, MD, Michael E. Ray, MD, PhD, Daniel A. Hamstra, MD, PhD

Get full text